SARS-CoV-2–neutralizing antibody treatment in patients with COVID-19 and immunodeficiency due to B-cell non-Hodgkin lymphoma

Detalles Bibliográficos
Autores principales: Malin, Jakob J., Di Cristanziano, Veronica, Horn, Carola, Pracht, Elisabeth, Garcia Borrega, Jorge, Heger, Eva, Knops, Elena, Kaiser, Rolf, Böll, Boris, Lehmann, Clara, Jung, Norma, Borchmann, Peter, Fätkenheuer, Gerd, Klein, Florian, Hallek, Michael, Rybniker, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683250/
https://www.ncbi.nlm.nih.gov/pubmed/34911078
http://dx.doi.org/10.1182/bloodadvances.2021006655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683250/
https://www.ncbi.nlm.nih.gov/pubmed/34911078
http://dx.doi.org/10.1182/bloodadvances.2021006655

Ejemplares similares